Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The in vitro effects of plictran on oligomycin-sensitive
Mg2+-ATPase
and Ca2+-ATPase activities in beef heart mitochondria were studied. Beef heart mitochondrial fractions were prepared by the conventional centrifugation method. ATPase activities were measured by determining the inorganic phosphate released by the hydrolysis of ATP.
Plictran
inhibited both oligomycin-sensitive (o.s.)
Mg2+-ATPase
and Ca2+ ATPase activities at nanomolar concentrations. However, plictran did not affect the oligomycin-insensitive (o.i.)
Mg2+-ATPase
activity at any concentration studied. Substrate activation kinetics revealed that plictran inhibited o.s.
Mg2+-ATPase
uncompetitively and Ca2+-ATPase non-competitively. These results clearly indicate that plictran affects ATP synthesis and calcium ion transport in beef heart mitochondria.
...
PMID:Effect of plictran on beef heart mitochondrial ATPases. 316 Dec 18